Access cutting-edge pancreatic cancer treatment through this clinical trial at a research site in Anchorage. Study-provided care at no cost to qualified participants.
Access pancreatic cancer specialists in Anchorage at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreatic cancer treatment provided free
This phase II/III trial compares the effect of the 3-drug chemotherapy combination of nab-paclitaxel, gemcitabine, plus cisplatin versus the 2-drug chemotherapy combination of nab-paclitaxel plus gemcitabine for the treatment of patients with pancreatic cancer that has spread to other places in the body (metastatic) and a known genetic mutation in the BRCA1, BRCA2, or PALB2 gene.
Sponsor: Alliance for Clinical Trials in Oncology
Check if you qualify for this pancreatic cancer clinical trial in Anchorage, AK
If you're searching for pancreatic cancer treatment options in Anchorage, AK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Anchorage research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.